Let's Build the Future of Cancer Diagnostics Together
Whether you're an investor, BioPharma partner, or clinical collaborator — we welcome the conversation about how the EPINUC™ platform can create value in your world.
Request the Pitch Deck
Get our comprehensive investor presentation — including platform data, application pipeline, market analysis, and capital plan.
Request Deck →Email the Team
General inquiries, partnership discussions, or scientific collaboration requests — we aim to respond within 48 hours.
info@epi-vision.com →Schedule a Meeting
Request a 30-minute introductory call with our CEO to discuss investment, partnership, or collaboration opportunities.
Schedule a Call →Who We're Looking to Connect With
EPIVISION's dual-market strategy creates partnership opportunities across multiple stakeholder categories.
Investors
Seed and early-stage investors evaluating differentiated liquid biopsy platforms with peer-reviewed clinical data and a dual-revenue model.
- Seed round pitch deck
- Financial model and projections
- Due diligence materials
- CEO intro call
BioPharma Partners
Oncology pharma companies seeking epigenetic biomarker tools for trial enrichment, patient stratification, or companion diagnostic co-development.
- Platform capability overview
- Feasibility study design
- Partnership term structures
- Scientific advisory engagement
Clinical Collaborators
Academic medical centers, clinical oncologists, and diagnostic laboratories interested in validation studies or early clinical access.
- Clinical study collaboration
- Sample access partnerships
- Research-use-only assay access
- Publication co-authorship
Ready to Start the Conversation?
One email is all it takes. Tell us what you're interested in and we'll route you to the right person on our team.